H-G Peptides HMG 75iu

<

Model NO.: HMG
Product Name: Epo
Spec: 75iu
Packing: Vials
Function: Bodybuilding
Appearance: White Freeze-Dried Powder
Mf: C50h69n15o9
MW: 1024.20
MOQ: 1kit
Standard: Enterprise Standard
Trademark: Shanghai Stero
Transport Package: Vials
Specification: 75iu
Origin: China
HS Code: 2937290023
Model NO.: HMG
Product Name: Epo
Spec: 75iu
Packing: Vials
Function: Bodybuilding
Appearance: White Freeze-Dried Powder
Mf: C50h69n15o9
MW: 1024.20
MOQ: 1kit
Standard: Enterprise Standard
Trademark: Shanghai Stero
Transport Package: Vials
Specification: 75iu
Origin: China
HS Code: 2937290023
H-G Peptides HMG 75iu


Quick detail:
 
Product name  High purity EPO(3000IU)
Specification 10mg/vial,10vial/box
MOQ  1box
MW.  1024.20
MF.  C50H69N15O9
Appearance   white freeze-dried powder
Sotre at  Cool dry place
 
Description:
 
hMG is produced from a sterile preparation of placental glucoprotein urine of post-menopausal women. The hMG is purified by proprietary chromatographic techniques.
Physical Appearance: Sterile Filtered White lyophilized (freeze-dried) powder.

HMG-CoA reductase (3-hydroxy-3-methyl-glutaryl-coenzyme A reductase, officially abbreviated HMGCR) is the rate-controlling enzyme (NADH-dependent, EC 1.1.1.88; NADPH-dependent, EC 1.1.1.34) of the mevalonate pathway, the metabolic pathway that produces cholesterol and other isoprenoids. Normally in mammalian cells this enzyme is suppressed by cholesterol derived from the internalization and degradation of low density lipoprotein (LDL) via the LDL receptor as well as oxidized species of cholesterol. Competitive inhibitors of the reductase induce the expression of LDL receptors in the liver, which in turn increases the catabolism of plasma LDL and lowers the plasma concentration of cholesterol, an important determinant of atherosclerosis.[4] This enzyme is thus the target of the widely available cholesterol-lowering drugs known collectively as the statins.
HMG-CoA reductase is anchored in the membrane of the endoplasmic reticulum, and was long regarded as having seven transmembrane domains, with the active site located in a long carboxyl terminal domain in the cytosol. More recent evidence shows it to contain eight transmembrane domains.[5]
In humans, the gene for HMG-CoA reductase is located on the long arm of the fifth chromosome (5q13.3-14).[6] Related enzymes having the same function are also present in other animals, plants and bacteria.


Structure
The main isoform (isoform 1) of HMG-CoA reductase in humans is 888 amino acids long. It is a polytopic transmembrane protein (meaning it possesses many alpha helical transmembrane segments). It contains two main domains:
an N-terminal sterol-sensing domain (amino acid interval: 88-218), which binds sterol groups. Cholesterol binding at this region inhibits the activity of the catalytic domain.
a C-terminal catalytic domain (amino acid interval: 489-871), namely the 3-hydroxy-3-methyl-glutaryl-CoA reductase domain. This domain is required for the proper enzymatic activity of the protein.
Isoform 2 is 835 amino acids long. This variant is shorter because it lacks an exon in the middle region. This does not affect any of the aforementioned domains.

 

Peptide List
Product Name Specification
ACE 031 1 mg/vial, 10 vials/kit
Follistatin 315 1 mg/vial, 10 vials/kit
Follistatin 344 1 mg/vial, 10 vials/kit
***************************** *****************************
MGF 2 mg/vial, 10 vials/kit
PEG - MGF 2 mg/vial, 10 vials/kit
DSIP 2 mg/vial, 10 vials/kit
TB500 2 mg/vial, 10 vials/kit
Oxytocin 2 mg/vial, 10 vials/kit
Hexarelin 2 mg/vial, 10 vials/kit
Triptorelin 2 mg/vial, 10 vials/kit
Ipamorelin 2 mg/vial, 10 vials/kit
Sermorelin 2 mg/vial, 10 vials/kit
Gonadorelin 2 mg/vial, 10 vials/kit
Tesamorelin 2 mg/vial, 10 vials/kit
BPC 157 2 mg/vial, 10 vials/kit
AOD-9604 2 mg/vial, 10 vials/kit
H 176-191 2 mg/vial, 10 vials/kit
CJC-1295 2 mg/vial, 10 vials/kit
CJC-1295 DAC 2 mg/vial, 10 vials/kit
***************************** *****************************
GHRP-2 5 mg/vial, 10 vials/kit
GHRP-6 5 mg/vial, 10 vials/kit
Selank 5 mg/vial, 10 vials/kit
***************************** *****************************
GHRP-2 10 mg/vial, 10 vials/kit
GHRP-6 10 mg/vial, 10 vials/kit
Epitalon 10 mg/vial, 10 vials/kit
PT-141 10 mg/vial, 10 vials/kit
Gonadorelin 10 mg/vial, 10 vials/kit
Melanotan II 10 mg/vial, 10 vials/kit
H-G Peptides HMG 75iu


Quick detail:
 
Product name  High purity EPO(3000IU)
Specification 10mg/vial,10vial/box
MOQ  1box
MW.  1024.20
MF.  C50H69N15O9
Appearance   white freeze-dried powder
Sotre at  Cool dry place
 
Description:
 
hMG is produced from a sterile preparation of placental glucoprotein urine of post-menopausal women. The hMG is purified by proprietary chromatographic techniques.
Physical Appearance: Sterile Filtered White lyophilized (freeze-dried) powder.

HMG-CoA reductase (3-hydroxy-3-methyl-glutaryl-coenzyme A reductase, officially abbreviated HMGCR) is the rate-controlling enzyme (NADH-dependent, EC 1.1.1.88; NADPH-dependent, EC 1.1.1.34) of the mevalonate pathway, the metabolic pathway that produces cholesterol and other isoprenoids. Normally in mammalian cells this enzyme is suppressed by cholesterol derived from the internalization and degradation of low density lipoprotein (LDL) via the LDL receptor as well as oxidized species of cholesterol. Competitive inhibitors of the reductase induce the expression of LDL receptors in the liver, which in turn increases the catabolism of plasma LDL and lowers the plasma concentration of cholesterol, an important determinant of atherosclerosis.[4] This enzyme is thus the target of the widely available cholesterol-lowering drugs known collectively as the statins.
HMG-CoA reductase is anchored in the membrane of the endoplasmic reticulum, and was long regarded as having seven transmembrane domains, with the active site located in a long carboxyl terminal domain in the cytosol. More recent evidence shows it to contain eight transmembrane domains.[5]
In humans, the gene for HMG-CoA reductase is located on the long arm of the fifth chromosome (5q13.3-14).[6] Related enzymes having the same function are also present in other animals, plants and bacteria.


Structure
The main isoform (isoform 1) of HMG-CoA reductase in humans is 888 amino acids long. It is a polytopic transmembrane protein (meaning it possesses many alpha helical transmembrane segments). It contains two main domains:
an N-terminal sterol-sensing domain (amino acid interval: 88-218), which binds sterol groups. Cholesterol binding at this region inhibits the activity of the catalytic domain.
a C-terminal catalytic domain (amino acid interval: 489-871), namely the 3-hydroxy-3-methyl-glutaryl-CoA reductase domain. This domain is required for the proper enzymatic activity of the protein.
Isoform 2 is 835 amino acids long. This variant is shorter because it lacks an exon in the middle region. This does not affect any of the aforementioned domains.

 

Peptide List
Product Name Specification
ACE 031 1 mg/vial, 10 vials/kit
Follistatin 315 1 mg/vial, 10 vials/kit
Follistatin 344 1 mg/vial, 10 vials/kit
***************************** *****************************
MGF 2 mg/vial, 10 vials/kit
PEG - MGF 2 mg/vial, 10 vials/kit
DSIP 2 mg/vial, 10 vials/kit
TB500 2 mg/vial, 10 vials/kit
Oxytocin 2 mg/vial, 10 vials/kit
Hexarelin 2 mg/vial, 10 vials/kit
Triptorelin 2 mg/vial, 10 vials/kit
Ipamorelin 2 mg/vial, 10 vials/kit
Sermorelin 2 mg/vial, 10 vials/kit
Gonadorelin 2 mg/vial, 10 vials/kit
Tesamorelin 2 mg/vial, 10 vials/kit
BPC 157 2 mg/vial, 10 vials/kit
AOD-9604 2 mg/vial, 10 vials/kit
H 176-191 2 mg/vial, 10 vials/kit
CJC-1295 2 mg/vial, 10 vials/kit
CJC-1295 DAC 2 mg/vial, 10 vials/kit
***************************** *****************************
GHRP-2 5 mg/vial, 10 vials/kit
GHRP-6 5 mg/vial, 10 vials/kit
Selank 5 mg/vial, 10 vials/kit
***************************** *****************************
GHRP-2 10 mg/vial, 10 vials/kit
GHRP-6 10 mg/vial, 10 vials/kit
Epitalon 10 mg/vial, 10 vials/kit
PT-141 10 mg/vial, 10 vials/kit
Gonadorelin 10 mg/vial, 10 vials/kit
Melanotan II 10 mg/vial, 10 vials/kit